Biomechanical Prānāyāma Breathing Involves the Anti- Inflammatory Reflex of the Vagus Nerve in Survival Imputation

Introduction

The human hypothalamic-pituitary-adrenal axis and melanocortin system represent the ancestral neuro-immune architecture of adaptability in the environment [1]. The constant across phylogenetic lines is the subset of the immune system in a hierarchical working agent for inter-operative and interdependence of other subsets. The bio-signals are the major players and regulation variables for encoding like-Alfvén low-frequency waves in structure- function interpolant workflow [2]. Hierarchically, end-of-life is the failure of host adaptative capabilities in high level of thermodynamic cycle of energy supply chain [3]. Energy production, oxidative phosphorylation and glycolytic processes are the intimate responses of self-maintenance in a flight of functional-structural change. Weight-energy needs fluid in and out of volume equation and scales of instability by stressors lead to extremely critical body conservation [4]. Microcirculation and endothelial subset are the multi-state gate space for thermodynamics of living and failure [5]. The high-level overview is the G-Protein Coupled receptors (i.e., GPCRs) family to control the local stability of binding energy and molecular docking cross the supply chain [6]. For instance, by Pharmacological Target Guide, developed by International Union of Basic and Clinical Pharmacology and British Pharmacological Society (i.e., IUPHAR/BPS) experts, identified the hardness of GPCRs in a the two-spin operator for driving the cAMP-dependent pathway [7]. Physiologically, real-time casual power are proportional gradients of hypoxic hyperinflammation reflex that generate energy distribution beds of mass fixative exchange and loop in the principal metabolic processes that occur. In recent years, it has been established that the extra-HPA immune control channels, are in a widespread distribution and chemotaxis with Vagus Nerve (i.e., VN) anisotropy through intermediaries onto cells-mitochondrial dynamics [8].

The Neuro-Immune Reflex

Nearly two decades the field research of “brain to immune system communication”, has elucidated the networking role of the inflammatory reflex [9]. The workload might be represented within a wired and wireless infrastructure of which the function is to over-order the hieratical control of microcirculation and oxygen flow transport to tissue and cells [10,11]. An anti-inflammatory role of the VN is observed using either vagal afferent and afferent’s, targeting cholinergic anti-inflammatory pathway by melanocortin receptor lies and GPCRs [12]. In this context, the VN provides a hub & spoke topology of wired network information for brain stem circuits and response interface for neuro-releasing factor. This is in a leukocyte traffic controller for the endothelial microvascular glycocalx gatekeeper [13]. The loops finalize the acetylcholine release in the reticule-endothelial system and signal transduction for inhibition of pro- inflammatory mediator’s pathways up to suppressor of cytokine signaling that negatively regulate the Janus Kinase/signal transducers and activator of transcription proteins. The plausibility and consistency of scientific data constitutes the basis of therapeutic use of VN stimulation by medical electric devices equipment with current pulsed at 25Hz through the skin for 2minutes. Devices are currently 510k FDA and EMA approved for patients aged>12 years with drug-resistant epilepsy, cardiac shock by arrythmia and recently Health Canada has granted the emergency use authorization for COVID-19 for treating COVID-19 cytokine storm and acute respiratory distress syndrome [14]. The expert opinion regards various clinical studies have been verified the safety and efficacy [15]. Conceptually, devices-less VN subthreshold stimulation may be reached by forced mechanical thorax exercise linked to Alfvén OM mantra low-frequency equation from as censored 44.1Kz to 2-fold emission by laryngeal vibration [16,17].

Prānāyāma

Complementary and alternative medicine is defined by the World Health Organization as the broad set of health‑care practices that are not part of that country’s own tradition and are not integrated into the dominant health‑care system. In this context Prānāyāma is generally defined as breath control with laryngeal harmonic sound. In view of the full quality attributes for neuro- immune axis properties, there are efficacy evidence on Quality- Adjusted Life years (QALYs) and Disability-Adjusted Life years (DALYs) [18]. Apply PICO model for evidence-based medicine-i.e., Population/Problem/Patient; Intervention/ Issue; Comparison; Outcome- by University of Illinois Chicago for overall Yoga therapeutic intervention, systematically it is assessed safety [19]. The assessment of DALYs by the Consort statement’s meta-analyze, was statistically relevant in benefit for screened 92 RCT of 490 in eligibility for a total of 8,430 sample size statistical [20]. To our knowledge, Prānāyāma’s short-term assessment in life-threatening and emergency situations has not been censored as in Kaplan Maier survival Imputation (KMI).

The Clinical Trial Identifier NCT04413747

The above assumption, rationale of Prānāyāma and pattern in real-world occurrence, have been blamed on Covid-19, which has multiple tricks up its lethality and challenges faced by the- “Yoga Pranayama Adjuvant to Treat Burden COVID-19” [21]. The play on a web-based platform was intended to promote horizontal subsidiarity and research opportunities while temporarily self-organizing for public health measures. The data set for 100 cases of coronavirus disease between February and March 2020 was collected during the protocol evaluation and used for sensitivity analysis. The purpose of this subgroup is to decrease bias in non-randomized trials and data gaps in the context of enrolling after the protocol date. Rapid changes in health outcomes after May 2020, while taking into consideration the complexity of emergency response notifications. Bayesian borrowing was employed to present the before-and-after study in a homogeneous data [22].

Material and Methods

Sensitivity analysis of Prānāyāma adjuvant in homecare by ICH E9 (R1) principle, was carried out on dataset of 100 enrolled consecutive confirmed SARS-CoV-2 infection [23]. The period was from February to May 2020, in the district of Emilia Romagna, in the north of Italy [24,25]. Paracetamol therapy for hyperpiesia without early anti-inflammatory drugs such as ibuprofen, corticosteroid up to hydroxychloroquine administration was the cut- off for inclusion criteria for homecare in the first-second stage of disease. The end point was 15-day mortality in hospitalization rate. The reviewer’ s design was in nonrandomized multi-state model and accelerated life- expectancy failure for early warning score NEWS2-COVID-19 alongside the full clinical assessment in primary care. Patients training and adjuvant treatment was for weekly repetitive cycles of “OM” laryngeal vibration and expiratory exercises onto Bhramari, Surya Bheda and Nadi Shodhana Prānāyāma in compressible language of Wester culture and emergency studied by S-VYASA University Bengalûru, India. DALYs and QALYs homecare was supervised by an ad hoc context for trained physicians, nurse, and physiotherapists in face-to-face consultation within a remote web-platform surveillance and intensive daily-line monitoring and testing. The offset test for efficacy in observed-to-expected outcome, was assessed in probability density function (PDF.) in a rankpreserving accelerated failure of life from per period daily epidemiological data. The time-to event in Kaplan Maier imputation (KMI) as Andersen-Gill recurrent event-time, were extracted by Official M-source statistic and used in Bayesian borrowing by the weight of PDF [26]. The reliability and efficacy were onto conditional Weibull survival in β shape and ή characteristic of life where 62.3% population have life-failure. Observe-to-Expected ratio as chi-squared test statistic for Prānāyāma contingently operator was compared with a posteriori-to-prior PDF. in k of β weight [25]. Parameters distribution were by conditional Weibull probability function [27]. The Relative Risk ratio (RR) and proportions defective of two side binomial confidence interval, were tested in point estimate of significance level.

Results and Discussion

The 100 enrolled case were within age range of 50-69yrs old as consecutive confirmed SARS-CoV-2 in principal stratum. The referred epidemiological data per area was 666,299 with pooled age of 44yr among 4,458.000 inhabitant. The stochastic demography was male-female ratio of 48/52%, georeferencing north in Italy 174.5 inhabitant Km2 density, mean age 46.6yr., pooled expected life span of 82.4yr. The general mortality rate of 13.3x1,000 in 2020 with increasing mortality rate per period of 17% with average of overall mortality from February to May of 22.553 cases of which 59.665, male 28.549 and female 31.116 [27]. In March 2020, 7.776 death more respect 2019 during first epidemic peak impact. The estimate of lethality rate for COVID-19 per period was respectively for age range of 50-59yr. and 60-69 yr. of 1.3 and 3.7% with a pooled approximation “de minimis” with of coeval treatment of a pooled 2% for >62 % in 15-day hospital death rate. The theater scenario was over 28x100.000 inhabitant, emergency calls per 100 hospital bed of which 2.2% for area medica and 1.8% intensive care unit. The probability density function truncated at 15-day mortality rate in infected-COVID-19 per area and age, give a probability life-failure of 0.02 in distribution and approximation for survival of k factor 6.5 in β shape and 14.92-day characteristic of life as 62 percentile parameters: PDF., f(t),R(7.00)= 1, mean life 14.27-day in η of 15-day distribution of characteristic life at right, unreliability F(t) 0.434, Hazard rate f(t)/R(t) of 0.373 within the end of second week [27]. The Prānāyāma contingently operator with proper left Tobit’s variable probability density risk assessment, resulted in observed noevent of 30-day mortality rate as life failure of 0.00, β shape block box of k factor >15. The coefficient in Weibull-k factor resulted in breadth narrowed density of 2.5 k ratio as >15% more probability of living in “Hypergeometric Optimization of Motif EnRichment algorithm” as difference in Rayleigh non-negative variable equivalent to a Chi-square cumulative distribution [28]. The two side P-value proportions defective of binomial confidence interval of cases having event-free 15-day mortality rate, resulted 95% CI 42.07- to-55.93 and significant level of p < 0.0001. The Relative Risk (RR) two-side binomial CI 97.5% was Lower bound 1.7 to Upper bound 2.306 was 1.98 as 19-fold decrease the risk of 15-day mortality rate. The for borrowing, resulted in point estimate a significance level of p=0.02 between lower p <0.001 and upper limit of p=0.081 values [29]. The Altman’s Number Needed to Treat (NNT) was benefit 50.500 CI 74.63 (harmed)-to ∞- 18.85 (benefit) as the estimated number of patients who need to be treated with the new treatment rather than the standard treatment (or no treatment) for one additional patient to benefit. The Bayesian borrowing for a larger true effect size for COVID-19 lethality 2020 have made possible to adjust the type I error below 5% of α inflation and increasing effect sizes.

Conclusion

Inferential estimates with reliability enabled the efficacy of the Prānāyāma exercise as a Bayesian contingent operator in survival imputation for epidemiological exceptional conditions of the COVID-19 outbreak. Although many limitations exist, it is correct to cite Prānāyāma as adjuvants for mild to moderate cases of hyperinflammation. As of mid-March, there was no evidence to claim anti-inflammatory drugs to worsen infection, so some public health bodies only recommend taking acetaminophen. The daily mortality ratio from COVID-19 was the primary estimate for care. The nested care for hyperinflammation may be considered a lowered confounding factor in this period. The primary data set’s reliability analysis is credible under the circumstances because the survey is not randomized due to the adjusted mortality rate harmonization. This implies that Prānāyāma can be considered safe and first-line in homecare containment of hyperinflammation disorders with a 19- fold decrease the risk in accelerated life-span failure.

Acknowledgements

Major thanks”: to entire staff of Yoga Committees Ayush University Swami Vivekananda Yoga Anusandhana Samsthana , Antonio Gaddi MD PhD President of Italian Telemedicine Association Rome, Italy, Daniele Bassi Mayor of the Municipality of Massa Lombarda, Italy, Cheti Sereafini Head of Nurse Health Care Giardino St Lucia Massa Lombarda Italy.

Conflict of Interest

We declare there is no financial interest, or any conflict of interest exists.

References

• DeMorrow S (2018) Role of the Hypothalamic-Pituitary-Adrenal Axis in Health and Disease. International Journal of Molecular Sciences 19(4): 986.
• Alflven H (1942) Existence of Electromagnetic- Hydrodynamic Waves. Nature 150: 405-406.
• Cleri F (2016) Thermodynamics for Living Systems. In: The Physics of Living Systems. Undergraduate Lecture Notes in Physics. Springer Cham.
• Dutta A, Chattopadhyay H (2021) A Brief on Biological Thermodynamics for Human Physiology. J Biomech Eng 143(7): 070802.
• Broz P Dixit V (2016) Inflammasomes: mechanism of assembly, regulation and signaling. Nat Rev Immunol 16(7): 407-420.
• Davenport A P, Scully CC, Chris de Graaf, Alastair J H Brown, Janet J Maguire, et al. (2020) Advances in therapeutic peptides targeting G protein-coupled receptors. Nat Rev Drug Discov 19(6): 389-413.
• Pawson AJ, Sharman JL, Benson HE, Elena Faccenda, Stephen P H Alexander, et al. (2014) NC-IUPHAR. The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res: D1098-106.
• Olofsson P (2018) Vagus Nerve Stimulation and Regulation of Inflammation, Editor(s): Elliot S Krames, P Hunter Peckham, Ali R Rezai, Neuromodulation (Second Edition), Academic Press: 1483-1492.
• Schiller M, Ben Shaanan TL, Rolls A (2021) Neuronal regulation of immunity: why, how and where? Nat Rev Immunol 21(1): 20-36.
• Munteanu C, Călin Dragoș MA, Popescu Mădălina MC, et al. (2023) Current data regarding homeostasis of tissues oxygenation in pathophysiological and therapeutic circumstances, Balneo and PRM Research Journal 14(2): 565.
• Giacomello M, Pyakurel A, Christina Glytsou, Luca Scorrano (2020) The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol 21(4): 204-224.
• Ge Yj, Liao Qw, Xu Yc, Qiang Zhao, BeiLi Wu, et al. (2020) Anti-inflammatory signaling through G protein-coupled receptors. Acta Pharmacol Sin 41(12): 1531-1538.
• Moore KH, Murphy HA, M George EM (2021) The glycocalyx: a central regulator of vascular function American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 320(4): R508-R518.
• Mertens A, Raedt R, Stefanie Gadeyne, Evelien Carrette, Paul Boon, et al. (2018) Recent advances in devices for vagus nerve stimulation. Expert Rev Med Devices 15(8): 527-539.
• McIntire LK, McKinley RA, Chuck Goodyear, John P McIntire, Rebecca D Brown, et al. (2021) Cervical transcutaneous vagal nerve stimulation (ctVNS) improves human cognitive performance under sleep deprivation stress. Commun Biol 4(1): 634.
• Gurjar A, Ladhake SA, Thakare AP (2009) Analysis of Acoustic of "OM" Chant to Study Its Effect on Nervous System.
• XQ Lu, LM Yu, W Guo, KH Li (2021) Ion flow driven by low frequency Alfvén waves in a low-beta plasma. Physics of Plasmas 28(2): 022903.
• Cramer H, Ward L, Robert Saper, Daniel Fishbein, Gustav Dobos, et al. (2015) The Safety of Yoga: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Epidemiology 182(4): 281-293.
• Kanchan J, Thapliyal A (2021) Physiology of Pranayama. International Journal for Modern Trends in Science and Technology 7(8): 116-119.
• Jayawardena R, Ranasinghe P, Himansa Ranawaka, Nishadi Gamage, Dilshani Dissanayake, et al. (2020) Exploring the therapeutic benefits of Pranayama (yogic breathing): A systematic review. Int J Yoga 13(2): 99-110.
• https: // classic. clinicaltrials.gov/ct2/show/ NCT04413747? term= Yoga& cond= COVID+19 & cntry= IT&draw =2& rank=1.
• Marušić MF, Fidahić M, Cepeha CM, Loredana Gabriela Farcaș, Alexandra Tseke, et al. (2020) Methodological tools and sensitivity analysis for assessing quality or risk of bias used in systematic reviews published in the high-impact anesthesiology journals. BMC Med Res Methodol 20: 121.
• EMA/CHMP/ICH/436221/2017, ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials.
• IHME COVID-19 Forecasting Team (2021) Modeling COVID-19 scenarios for the United States. Nat Med 27(1): 94-105.
• Official website of Emilia Romagna Region, Italy.
• Kaplan D, Chen J, Yavuz S, Weicong Lyu (2023) Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments. Psychometrika 88(1): 1-30.
• Nelson W (2003) Applied Life Data Analysis, Wiley-Interscience; 1^st edition Print ISBN: 9780471094586.
• Heinz S, Benner C, Spann N, Eric Bertolino, Yin C Lin, et al. Simple (2010) Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities. Mol Cell 38(4): 576-589.
• Neubauer J (2014) Battery Lifetime Analysis and Simulation Tool (BLAST) Documentation, NREL/TP-5400- 63246.